What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
Int J Ophthalmol
.
2022 Sep 18;15(9):1413-1415.
doi: 10.18240/ijo.2022.09.01.
eCollection 2022.
Author
Peter Wiedemann
1
Affiliation
1
Medical Faculty, Leipzig University, Leipzig 04103, Germany.
PMID:
36124195
PMCID:
PMC9453418
DOI:
10.18240/ijo.2022.09.01
No abstract available
Publication types
Editorial